当前位置:
X-MOL 学术
›
JACC Heart Fail.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Optimal Medical Therapy and Outcomes Among Patients With Chronic Heart Failure With Reduced Ejection Fraction
JACC: Heart Failure ( IF 10.3 ) Pub Date : 2024-08-07 , DOI: 10.1016/j.jchf.2024.05.026 Vishal N Rao 1 , Anne S Hellkamp 2 , Laine E Thomas 2 , Gregg C Fonarow 3 , Mona Fiuzat 2 , Christopher M O'Connor 4 , John A Spertus 5 , Akshay S Desai 6 , Nancy M Albert 7 , Javed Butler 8 , Adrian F Hernandez 9 , Adam D DeVore 9
JACC: Heart Failure ( IF 10.3 ) Pub Date : 2024-08-07 , DOI: 10.1016/j.jchf.2024.05.026 Vishal N Rao 1 , Anne S Hellkamp 2 , Laine E Thomas 2 , Gregg C Fonarow 3 , Mona Fiuzat 2 , Christopher M O'Connor 4 , John A Spertus 5 , Akshay S Desai 6 , Nancy M Albert 7 , Javed Butler 8 , Adrian F Hernandez 9 , Adam D DeVore 9
Affiliation
Optimal medical therapy (OMT) scoring may stratify clinical risk in real-world chronic heart failure with reduced ejection fraction (HFrEF) by integrating use and dosing of guideline-directed medical therapy (GDMT) for HFrEF.
中文翻译:
射血分数降低的慢性心力衰竭患者的最佳药物治疗和结局
最佳药物治疗 (OMT) 评分可以通过整合 HFrEF 指南指导药物治疗 (GDMT) 的使用和剂量,对真实世界射血分数降低的慢性心力衰竭 (HFrEF) 的临床风险进行分层。
更新日期:2024-08-07
中文翻译:
射血分数降低的慢性心力衰竭患者的最佳药物治疗和结局
最佳药物治疗 (OMT) 评分可以通过整合 HFrEF 指南指导药物治疗 (GDMT) 的使用和剂量,对真实世界射血分数降低的慢性心力衰竭 (HFrEF) 的临床风险进行分层。